{"id":"1278863a","safety":{"commonSideEffects":[{"rate":"30-50%","effect":"Neutropenia"},{"rate":"20-40%","effect":"Anemia"},{"rate":"10-30%","effect":"Thrombocytopenia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by inhibiting the PI3K delta subunit, which is involved in the activation of B cells. This leads to a reduction in the activity of B cells, which are a type of immune cell that plays a key role in the development of autoimmune diseases.","oneSentence":"This drug is a small molecule that targets the PI3K delta subunit.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:24:52.738Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic lymphocytic leukemia (CLL)"},{"name":"Sjögren's syndrome"}]},"trialDetails":[{"nctId":"NCT00935831","phase":"PHASE1","title":"Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-08-12","conditions":"Kidney Disease","enrollment":12},{"nctId":"NCT00840320","phase":"PHASE1","title":"Repeat Dose Safety Study for Compound to Treat Anemia","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-03-13","conditions":"Kidney Disease","enrollment":24},{"nctId":"NCT01047397","phase":"PHASE2","title":"Repeat Dose Safety and Efficacy Study for Compound to Treat Anemia","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-03","conditions":"Kidney Disease","enrollment":107}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"1278863A","genericName":"1278863A","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug is a small molecule that targets the PI3K delta subunit. Used for Chronic lymphocytic leukemia (CLL), Sjögren's syndrome.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}